Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of pharmacogenomics in individualising treatment with SSRIs.

CNS drugs - 1 Jan 2003

Mancama Dalu, Kerwin Robert W

Abstract excerpt

The introduction of the SSRIs has significantly transformed the pharmacological treatment of a range of psychiatric disorders. In particular, individuals affected by depression, panic disorder, obsessive-compulsive disorder and social phobia have benefited substantially from their use. Compared with the previous generation of psychotropic drugs, SSRIs offer an improved tolerability to therapy while maintaining a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Variation
Share to Individuality
Share to Mental Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Selective Serotonin Reuptake Inhibitors

Share to Treatment Outcome

Source

Identifiers

PMID: 12617694
DOI: 10.2165/00023210-200317030-00001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of pharmacogenomics in individualising treatment with SSRIs.PMID 12617694Read ↗

Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?Semantic proximity Read ↗

Pharmacogenetic considerations in the treatment of psychiatric disorders.Semantic proximity Read ↗

Pharmacogenomics of antidepressant drugs.Semantic proximity Read ↗

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Semantic proximity Read ↗

Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studiesSemantic proximity Read ↗

The emerging role of pharmacogenetics: implications for clinical psychiatry.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Semantic proximity Read ↗

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic TherapySemantic proximity Read ↗

Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.Semantic proximity Read ↗

Genetics and personalized medicine in antidepressant treatment.Semantic proximity Read ↗

Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Practical issues related to medication selection.Semantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.